Bicycle Therapeutics (BCYC) Enterprise Value (2018 - 2025)
Bicycle Therapeutics' Enterprise Value history spans 8 years, with the latest figure at -$628.1 million for Q4 2025.
- For Q4 2025, Enterprise Value rose 28.58% year-over-year to -$628.1 million; the TTM value through Dec 2025 reached -$628.1 million, up 28.58%, while the annual FY2025 figure was -$628.1 million, 28.58% up from the prior year.
- Enterprise Value reached -$628.1 million in Q4 2025 per BCYC's latest filing, up from -$648.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$198.7 million in Q2 2021 to a low of -$961.4 million in Q2 2024.
- Average Enterprise Value over 5 years is -$531.1 million, with a median of -$457.0 million recorded in 2024.
- Peak YoY movement for Enterprise Value: tumbled 222.58% in 2021, then rose 28.58% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$438.7 million in 2021, then increased by 22.69% to -$339.2 million in 2022, then crashed by 55.22% to -$526.4 million in 2023, then crashed by 67.07% to -$879.5 million in 2024, then grew by 28.58% to -$628.1 million in 2025.
- Per Business Quant, the three most recent readings for BCYC's Enterprise Value are -$628.1 million (Q4 2025), -$648.3 million (Q3 2025), and -$721.5 million (Q2 2025).